Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
Want to see IN:JUBLPHARMA full AI Analyst Report?
Total Valuation
Jubilant Pharmova Limited has a market cap or net worth of ₹156.35B. The enterprise value is ₹180.91B.
Market Cap₹156.35B
Enterprise Value₹180.91B
Share Statistics
Jubilant Pharmova Limited has 159,281,140 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding159,281,140
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jubilant Pharmova Limited’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 3.99%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.99%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee15.34M
Profits Per Employee738.10K
Employee Count5,399
Asset Turnover0.53
Inventory Turnover4.70
Valuation Ratios
The current PE Ratio of Jubilant Pharmova Limited is 39.4. Jubilant Pharmova Limited’s PEG ratio is -0.62.
PE Ratio39.4
PS Ratio1.56
PB Ratio1.82
Price to Fair Value1.82
Price to FCF-29.66
Price to Operating Cash Flow42.60
PEG Ratio-0.62
Income Statement
In the last 12 months, Jubilant Pharmova Limited had revenue of 82.80B and earned 3.98B in profits. Earnings per share was 25.15.
Revenue82.80B
Gross Profit24.94B
Operating Income8.19B
Pretax Income6.14B
Net Income3.98B
EBITDA12.66B
Earnings Per Share (EPS)25.15
Cash Flow
In the last 12 months, operating cash flow was 3.69B and capital expenditures -7.40B, giving a free cash flow of -3.71B billion.
Operating Cash Flow3.69B
Free Cash Flow-3.71B
Free Cash Flow per Share-23.27
Dividends & Yields
Jubilant Pharmova Limited pays an annual dividend of ₹5, resulting in a dividend yield of 0.46%
Dividend Per Share₹5
Dividend Yield0.46%
Payout Ratio15.92%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-11.24%
50-Day Moving Average956.97
200-Day Moving Average1.01K
Relative Strength Index (RSI)55.97
Average Volume (3m)7.42K
Important Dates
Jubilant Pharmova Limited upcoming earnings date is Jul 17, 2026, TBA (Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateJul 17, 2026
Ex-Dividend Date―
Financial Position
Jubilant Pharmova Limited as a current ratio of 1.62, with Debt / Equity ratio of 50.96%
Current Ratio1.62
Quick Ratio1.13
Debt to Market Cap0.25
Net Debt to EBITDA1.85
Interest Coverage Ratio3.87
Taxes
In the past 12 months, Jubilant Pharmova Limited has paid 2.17B in taxes.
Income Tax2.17B
Effective Tax Rate0.35
Enterprise Valuation
Jubilant Pharmova Limited EV to EBITDA ratio is 12.07, with an EV/FCF ratio of -35.04.
EV to Sales1.85
EV to EBITDA12.07
EV to Free Cash Flow-35.04
EV to Operating Cash Flow15.09
Balance Sheet
Jubilant Pharmova Limited has ₹6.23B in cash and marketable securities with ₹28.83B in debt, giving a net cash position of -₹22.60B billion.
Cash & Marketable Securities₹6.23B
Total Debt₹28.83B
Net Cash-₹22.60B
Net Cash Per Share-₹141.86
Tangible Book Value Per Share₹188.89
Margins
Gross margin is 38.45%, with operating margin of 9.90%, and net profit margin of 4.81%.
Gross Margin38.45%
Operating Margin9.90%
Pretax Margin7.42%
Net Profit Margin4.81%
EBITDA Margin15.29%
EBIT Margin9.98%
Analyst Forecast
The average price target for Jubilant Pharmova Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast14.45%
EPS Growth Forecast-52.50%